Jakob Brix Christensen

Jakob Brix Christensen is a seasoned finance professional with extensive experience in the biotech, pharmaceutical, and medical industries. Jakob Brix has held leadership roles in companies such as Unibio, BioPorto A/S, Novozymes, and ORIGIO, where Jakob Brix managed finance, investor relations, and business development. Jakob Brix has also worked as a financial advisor in mergers and acquisitions at Handelsbanken Capital Markets. Jakob holds a Master's degree in Economics and Business Administration and has completed additional education in leadership and finance.